Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum

Clinical and Vaccine Immunology

Volumn 17, Issue 5, 2010, Pages 836-839

  Hackett, Daniel J ^a   Zhang, Changpin ^a   Stefanescu, Carla ^a   Pass, Robert F ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; GLYCOPROTEIN B ANTIBODY; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CLINICAL LABORATORY TECHNIQUES; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SERUM; VIRAL ENVELOPE PROTEINS; YOUNG ADULT;

EID: 77952001394     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00422-09     Document Type: Article

References (14)

1. Bernstein, D. I., M. R. Schleiss, K. Berencsi, E. Gonczol, M. Dickey, P. Khoury, C. Cadoz, C. Meric, J. Zahradnik, A.-M. Duliege, and S. A. Plotkin. 2002. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. J. Infect. Dis. 185:686-690.
2. Britt, W., and M. Mach. 1996. Human cytomegalovirus glycoproteins. Intervirology 39:401-412.
3. Compton, T., D. M. Nowlin, and N. R. Cooper. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface haparan sulfate. Virology 193:834-841. (Pubitemid 23196503)
4. Frey, S. E., H. Harrison, R. F. Pass, E. Yang, D. Boken, R. E. Sekulovich, S. Percell, A. E. Izu, S. Hirabayashi, R. L. Burke, and A.-M. Duliege. 1999. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine. J. Infect. Dis. 180:1700-1703.
5. Marshall, G. S., G. P. Rabalais, G. G. Stout, and S. L. Waldeyer. 1992. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J. Infect. Dis. 165:381-384.
6. Navarro, D., E. Lennette, S. Tugizov, and L. Pereira. 1997. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J. Med. Virol. 52:451-459.
7. Navarro, D., P. Paz, S. Tugizov, K. Topp, J. LaVail, and L. Pereira. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
8. Pass, R. F., and R. L. Burke. 2002. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection. Semin. Pediatr. Infect. Dis. 13:196-204.
9. Pass, R. F., A.-M. Duliege, S. Boppana, R. Sekulovich, S. Percell, W. Britt, and R. L. Burke. 1999. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J. Infect. Dis. 180:970-975.
10. Pass, R. F., C. Zhang, A. Evans, T. Simpson, W. Andrews, M.-L. Huang, L. Corey, J. Hill, E. Davis, C. Flanigan, and G. Cloud. 2009. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360:1191-1199.
11. Reap, E. A., S. A. Dryga, J. Morris, B. Rivers, P. Norberg, R. A. Olmsted, and J. D. Chulay. 2007. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1 and gB proteins. Clin. Vaccine Immunol. 14:748-755.
12. Spaete, R. R. 1991. A recombinant subunit vaccine approach to HCMV vaccine development. Transplant. Proc. 23:90-96.
13. Tugizov, S., D. Navarro, P. Paz, Y. Wang, I. Qadri, and L. Pereira. 1994. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology 201:263-276.
14. Wloch, M. K., L. R. Smith, B. Souphaphone, L. Reyes, C. Han, J. Kehler, H. D. Smith, L. Selk, R. Nakamura, J. M. Brown, T. Marbury, A. Wald, A. Rolland, D. Kaslow, T. Evans, and M. Boeckh. 2008. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J. Infect. Dis. 197:1634-1642.